Terumo India, the Indian arm of Japanese firm Terumo Corporation, has signed a partnership with Israel-based Sensible Medical Innovations, a market leader in medical radar monitoring and imaging technology (ReDS), that grants it exclusive distribution rights for ReDS Pro and knowledge-sharing of ReDS technology in India.

ReDS Pro is used to measure the absolute lung fluid volume in patients, which has strong correlation with symptoms of Coronary Heart Failure (CHF). It is a non-invasive method that takes only 45 seconds to measure. Lung fluid assessment with ReDS Pro is proven to be as accurate as that measured by a CT scan. 

Periodic monitoring through ReDS Pro and titration of medicines in heart failure patients can potentially reduce hospitalization rates by 30%. ReDS technology has been adapted for medical use from an Israeli military application where it was used to see through walls.